Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
February 2007
2007:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2006 | 2008
News | News in brief | News Features
News
Cloning special: Dolly: a decade on
The advances in technology that lead to the birth of Dolly, the first mammal cloned from adult somatic cells, a decade ago have been applied towards medical and biological research, rather than human reproduction.
Nature (22 February 2007)
| Full Text |
Cloning special: Dolly: a hard act to follow
The difficulty in cloning mammals has dampened dreams of cloned pets and herds of livestock, but shifted attention to epigenetic factors involved in reprogramming adult cell nuclei.
Nature (22 February 2007)
| Full Text |
Japanese TV show admits faking science
A Japanese 'infotainment' show is cancelled after broadcasting fake reports involving mice that never sleep and the 'science of face thinning.'
Nature (22 February 2007)
| Full Text |
Broad sweep of genome zeroes in on diabetes
Genome-wide association studies of people with type 2 diabetes uncover four genomic regions that confer a significant risk to developing the disease.
Nature (15 February 2007)
| Full Text |
Key biology databases go wiki
'Wiki for Professionals' weaves together scientific databases (including Swiss-Prot and Gene Ontology) into entries which users can edit and modify.
Nature (15 February 2007)
| Full Text |
Bush and Congress set debate on priorities
President Bush and the Democrat-led Congress prepare to debate the 2008 federal scientific research budget.
Nature (8 February 2007)
| Full Text |
Virus paper reignites prion spat
A paper in Proceedings of the National Academy of Sciences challenges conventional wisdom on brain disease.
Nature (8 February 2007)
| Full Text |
Tied up in red tape, European trials shut down
The European Clinical Trials Directive, founded to improve safety and consistency of drug trials, has instead created bureaucratic nightmares for participating institutions.
Nature Medicine (February 2007)
| Full Text |
Ambitious scheme for developing world trials in 'big trouble'
The four-year-old European and Developing Countries Clinical Trials Program has been plagued by grant squabbles and poor communication, and its potential remains largely unfulfilled.
Nature Medicine (February 2007)
| Full Text |
US proposal to expand access to untested drugs draws fire
The US Food and Drug Administration proposed a controversial scheme to help gravely ill people get drugs that are still in early-stage clinical trials.
Nature Medicine (February 2007)
| Full Text |
British scientists find patent loophole
Two British researchers say they have found a way to produce low-cost versions of expensive pharmaceuticals without breaking patent laws by changing the position of innocuous sugar groups in the molecules.
Nature Medicine (February 2007)
| Full Text |
Commercial interest grows in glycan analysis
A Dublin group has developed a high-throughput method for analyzing sugar structures on proteins, which they hope will open up the arcane field of glycan analysis to a wider audience.
Nature Biotechnology (February 2007)
| Full Text |
Next-generation sequencing outpaces expectations
Growing demand in both the research and clinical markets is fueling the development — and funding — of more efficient genomic sequencing methods.
Nature Biotechnology (February 2007)
| Full Text |
Democrats prioritize pricing, generics and drug safety
The new Democrat-led Congress is likely to challenge existing regulations that would affect drug prices, biodefense programs, and stem cell research.
Nature Biotechnology (February 2007)
| Full Text |
California institute woos NIH stem-cell chief
The California Institute for Regenerative Medicine (CIRM) is courting the top stem-cell official at the US National Institutes of Health (NIH) to take over as its president.
Nature (1 February 2007)
| Full Text |
Infertility researchers target uterus transplant
A team from New York headed by Giuseppe Del Priore plans to provide an infertile woman with a transplanted uterus — only the second such attempt in the world.
Nature (1 February 2007)
| Full Text |
Michigan lab axed as Pfizer cuts costs
Pfizer announced in January that it will close its Ann Arbor laboratory by the end of next year - part of a plan to cut between $1.5 billion and $2 billion from its annual costs.
Nature (1 February 2007)
| Full Text |
News in brief
Kansas puts evolution back on the curriculum
| Biologist calls time on hunger strike at MIT
| Healthcare company takes lead with biobank
| Historian to lead science forward at Harvard
| Catholic college sells land, but blocks stem-cell work
| Horse genome to help human conditions
| Trials halt after gel found to increase HIV risk
| Cloners take different views over best recipe
| Campaigning for open access gets easier
| Academic starts hunger strike for tenure at MIT
| Australia ends stem-cell cloning ban
| FDA clarifies stance on long-term follow-up for gene therapy clinical trials
| Terror fears prompt tighter controls for UK labs
| US set to embrace law on genetic discrimination
News Features
Plant biology: The flower of seduction
Hundreds of orchid species trick male insects into pollinating them by emitting pheromones that mimic the scent of female insects.
Nature (22 February 2007)
| Full Text |
India's watchdog: A breath of fresh air
How often does independent research change laws as well as minds? A lobby group in Delhi is forcing the Indian government into new regulations.
Nature (15 February 2007)
| Full Text |
Reproductive medicine: The first cut
Extracting a cell from a budding human embryo can expose genetic defects, but does it actually help generate more healthy babies?
Nature (1 February 2007)
| Full Text |
|
